Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer ; volume:5 ; number:1 ; day:3 ; month:6 ; year:2010 ; pages:1-6 ; date:12.2010
Radiation oncology ; 5, Heft 1 (3.6.2010), 1-6, 12.2010
- Creator
-
Kitayama, Joji
- Contributor
-
Yasuda, Koji
Kawai, Kazushige
Sunami, Eiji
Nagawa, Hirokazu
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-5-47
- URN
-
urn:nbn:de:1111-2016072613284
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kitayama, Joji
- Yasuda, Koji
- Kawai, Kazushige
- Sunami, Eiji
- Nagawa, Hirokazu
- SpringerLink (Online service)
Other Objects (12)
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy